New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Thursday 19 November 2026
Export BBWI’s income statement to Excel — free account
Bath & Body Works, Inc.
BBWIConsumer Cyclical Specialty Retail
Bath & Body Works, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $7.3 billion, roughly unchanged from fiscal 2025.
- Revenue
- −2.26%
- EPS
- +93.3%
- Free cash flow
- n/m
- Total debt
- −7.05%
Quarter to July 2026, against a year earlier
18.94
0.29
+1.55%
Follow BBWI
Alert me
Ratios over time Q3 FY26 to Q2 FY27
Returns on capital
ROIC was 42.7% in Q2 FY27, against a low of 36.5% in Q3 FY26.
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| ROE | −41.9% | −48.8% | −56.3% | −60.0% |
| ROIC | 36.5% | 42.4% | 43.2% | 42.7% |
Debt
Net debt is 10.25× a year’s EBITDA.
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Net debt / EBITDA | 16.3× | 4.4× | 9.6× | 10.3× |
Cash cycle, in days
Customers pay in 8 days, inventory is held 80 days and suppliers are paid in 61. Cash is tied up for 27 days between paying for goods and being paid.
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Cash cycle | 50 | 30 | 25 | 27 |
| Days to pay suppliers | 69 | 41 | 49 | 61 |
| Days to be paid | 8 | 9 | 5 | 8 |
Per share, from Q3 FY26
Since Q3 FY26, per share: free cash flow has grown 11.9%; revenue has fallen 0.0%.
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Free cash flow | 1.0× | 0.9× | 1.0× | 1.1× |
| Revenue | 1.0× | 1.0× | 1.0× | 1.0× |
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 7 |
+8 more TTM periods Free account |
| (60.05%) | (56.33%) | (48.76%) | (41.86%) | ||
| 15.67% | 14.77% | 13.06% | 14.02% | ||
ROIC |
42.72% | 43.17% | 42.39% | 36.52% | |
Return on Tangible Assets |
53.90% | 44.66% | 41.74% | 47.55% | |
Average Days of Receivables |
7.80 | 4.94 | 9.01 | 8.39 | |
Free Cash Flow per Share |
5.21 | 4.61 | 4.20 | 4.66 | |
Free Cash Flow |
1,048.00 | 926.00 | 874.00 | 955.00 | |
Capital Expenditures |
(225.00) | (232.00) | (228.00) | (225.00) | |
| Other line items | |||||
Cash ROIC |
31.25% | 28.04% | 24.51% | 37.69% | |
Accounts Receivable Turnover |
50.60 | 72.09 | 37.88 | 39.86 | |
Accounts Payable Turnover |
6.48 | 8.16 | 10.22 | 6.36 | |
Inventory Turnover |
4.33 | 4.98 | 5.73 | 3.38 | |
Average Days of Payables |
61.26 | 49.41 | 41.38 | 69.39 | |
Days of Inventory on Hand |
80.01 | 69.36 | 62.20 | 111.15 | |
Tax Rate |
(0.20) | (0.19) | (0.26) | (0.27) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
27.39% | 27.36% | 28.30% | 27.75% | |
Share Based Compensation of Revenue |
0.32% | 0.40% | 0.43% | 0.46% | |
Interest Coverage |
4.49 | 4.19 | 4.08 | 4.26 | |
Operating CF/Net income |
1.63 | 1.59 | 1.70 | 1.69 | |
Depreciation/Fixed assets |
0.22 | 0.23 | 0.23 | 0.23 | |
Capex/Depreciation |
(0.91) | (0.92) | (0.90) | (0.86) | |
Revenue per Share |
35.87 | 36.04 | 35.05 | 35.87 | |
Operating CF per Share |
6.33 | 5.76 | 5.30 | 5.76 | |
Capex per Share |
(1.12) | (1.15) | (1.10) | (1.10) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates